From: Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
Variable | HR (95% CI) | p value |
---|---|---|
Gleason score (≤ 7, ≥ 8) | 2.35 (1.03–5.36) | 0.043 |
iPSA (< 10 ng/ml, ≥ 10 ng/ml) | 1.36 (0.61–3.01) | 0.454 |
Dose (35 vs. 36.25 Gy) | 1.10 (0.41–2.98) | 0.846 |
ADT (no vs. yes) | 3.72 (1.06–13.14) | 0.041 |